Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.63B | 1.64B | 1.72B | 1.41B | 1.74B | Gross Profit |
165.58M | 88.15M | 123.00M | 75.00M | 138.00M | EBIT |
39.48M | -65.26M | 26.00M | -11.00M | 27.00M | EBITDA |
39.00M | 81.32M | 172.33M | 121.82M | 92.99M | Net Income Common Stockholders |
-39.00M | -101.83M | -25.00M | -48.00M | 1.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
125.22M | 75.77M | 152.00M | 253.00M | 94.00M | Total Assets |
2.13B | 2.18B | 2.35B | 2.44B | 2.53B | Total Debt |
23.38M | 796.62M | 853.00M | 929.00M | 1.08B | Net Debt |
-101.84M | 720.85M | 701.00M | 676.00M | 990.00M | Total Liabilities |
1.41B | 1.44B | 1.52B | 1.63B | 1.83B | Stockholders Equity |
713.88M | 746.45M | 829.00M | 814.00M | 695.00M |
Cash Flow | Free Cash Flow | |||
95.67M | 8.60M | -69.00M | 137.00M | 47.00M | Operating Cash Flow |
203.61M | 136.27M | 69.00M | 232.00M | 124.00M | Investing Cash Flow |
-108.00M | -127.28M | -94.00M | 86.00M | -78.00M | Financing Cash Flow |
-42.48M | -86.95M | -73.00M | -156.00M | -19.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
58 Neutral | $405.70M | 33.74 | -5.11% | ― | -10.55% | -203.13% | |
55 Neutral | $317.74M | ― | -5.75% | ― | -0.79% | 62.16% | |
52 Neutral | $258.41M | 4.60 | -5.41% | 8.44% | -13.97% | 84.07% | |
52 Neutral | $243.77M | ― | -0.63% | ― | 186.18% | -125.58% | |
47 Neutral | $362.44M | ― | -15.99% | 5.54% | 2.48% | 65.00% | |
47 Neutral | $2.43B | -3.11 | -22.65% | 3.59% | 4.02% | -28.96% | |
45 Neutral | $262.80M | ― | -9.65% | ― | -25.69% | 18.54% |
Rayonier Advanced Materials Inc. (RYAM) has secured €67 million in green capital to bolster its biomaterials strategy. This financing includes €37 million in secured term loans from French banks and a €30 million preferred equity investment from SWEN Capital Partners, granting them a 20% stake in RYAM’s new subsidiary, BioNova. The funds will support projects like a bioethanol plant, aiming to generate over $40 million in EBITDA by 2027, showcasing RYAM’s commitment to growth and sustainability.
Rayonier A.M. Products Inc., a subsidiary of Rayonier Advanced Materials Inc., has extended its revolving credit facility maturity to 2029, reducing the commitment from $200 million to $175 million. Additionally, the company secured $700 million in term loans to refinance existing debt, including the redemption of its 2026 senior secured notes. This financial maneuver aims to optimize their debt structure and strengthen their financial position.
Rayonier Advanced Materials Inc. has successfully completed its cash tender offer to buy back its subsidiary’s 7.625% Senior Secured Notes due 2026, totaling $135.5 million, which represents nearly 30% of the outstanding notes. This strategic move by the global cellulose leader underscores its commitment to strengthening its financial position while continuing its operations across the U.S., Canada, and France.